Pharmos (PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr. John M. de Castro who wrote (887)	9/4/1999 8:45:00 PM
From: arnie h	Read Replies (1) of 1386

Dr John: <Preoperative and postoperative medications used for cataract surgery.> Thanks for calling this review to my attention. I had seen something on this earlier in the year and it certainly seemed like another good arrow in the quiver. I've not seen any PARS revenues attached to this indication but it would seem to be a useful and important application. Are you or anyone else on the thread aware of the use of LE for cataract surgery? Also, whether further FDA approval is required? Arnie

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next